VOYA Investment Management
VRTX icon

VOYA Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

VOYA Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$235M Sell
527,047
-35,305
-6% -$16.5M 0.24% 98
2025
Q4 		$254M Buy
562,352
+130,095
+30% +$56.1M 0.25% 85
2025
Q3 		$169M Sell
432,257
-267,387
-38% -$112M 0.17% 138
2025
Q2 		$311M Sell
699,644
-127,494
-15% -$58.8M 0.31% 65
2025
Q1 		$401M Buy
827,138
+128,432
+18% +$59.8M 0.45% 38
2024
Q4 		$281M Sell
698,706
-239,345
-26% -$111M 0.29% 63
2024
Q3 		$436M Sell
938,051
-544,625
-37% -$262M 0.45% 35
2024
Q2 		$695M Buy
1,482,676
+543,250
+58% +$236M 0.68% 16
2024
Q1 		$392M Buy
939,426
+163,938
+21% +$69.3M 0.38% 51
2023
Q4 		$315M Sell
775,488
-83,547
-10% -$30.9M 0.32% 56
2023
Q3 		$298M Buy
859,035
+32,080
+4% +$11.2M 0.33% 59
2023
Q2 		$291M Sell
826,955
-82,280
-9% -$27.7M 0.3% 76
2023
Q1 		$286M Sell
909,235
-285,922
-24% -$85.8M 0.31% 67
2022
Q4 		$345M Buy
1,195,157
+246,336
+26% +$75.1M 0.4% 46
2022
Q3 		$275M Buy
948,821
+698,774
+279% +$201M 0.33% 61
2022
Q2 		$70.5M Buy
250,047
+137,679
+123% +$36.9M 0.18% 124
2022
Q1 		$29.3M Sell
112,368
-3,479
-3% -$826K 0.06% 253
2021
Q4 		$25.4M Sell
115,847
-13,143
-10% -$2.56M 0.05% 312
2021
Q3 		$23.4M Sell
128,990
-6,293
-5% -$1.23M 0.05% 284
2021
Q2 		$27.3M Sell
135,283
-14,344
-10% -$3M 0.05% 258
2021
Q1 		$32.2M Sell
149,627
-9,136
-6% -$2.01M 0.06% 229
2020
Q4 		$37.5M Sell
158,763
-654,859
-80% -$150M 0.08% 218
2020
Q3 		$221M Sell
813,622
-37,913
-4% -$10.5M 0.49% 46
2020
Q2 		$247M Sell
851,535
-173,885
-17% -$47.1M 0.57% 31
2020
Q1 		$244M Sell
1,025,420
-28,399
-3% -$6.51M 0.66% 30
2019
Q4 		$231M Buy
1,053,819
+5,764
+0.5% +$1.17M 0.48% 49
2019
Q3 		$178M Sell
1,048,055
-29,920
-3% -$5.29M 0.39% 57
2019
Q2 		$198M Sell
1,077,975
-25,854
-2% -$4.52M 0.42% 56
2019
Q1 		$203M Sell
1,103,829
-12,949
-1% -$2.39M 0.46% 55
2018
Q4 		$185M Sell
1,116,778
-286,756
-20% -$49.7M 0.46% 53
2018
Q3 		$271M Buy
1,403,534
+40,376
+3% +$7.19M 0.56% 38
2018
Q2 		$232M Buy
1,363,158
+243,077
+22% +$37.7M 0.49% 45
2018
Q1 		$183M Buy
1,120,081
+1,026,874
+1,102% +$168M 0.39% 65
2017
Q4 		$14M Sell
93,207
-3,791
-4% -$561K 0.03% 502
2017
Q3 		$14.7M Sell
96,998
-871
-0.9% -$131K 0.03% 483
2017
Q2 		$12.6M Buy
97,869
+2,785
+3% +$335K 0.03% 533
2017
Q1 		$10.4M Buy
95,084
+107
+0.1% +$9.42K 0.02% 596
2016
Q4 		$7M Buy
94,977
+654
+0.7% +$53.2K 0.02% 687
2016
Q3 		$8.23K Buy
94,323
+72
+0.1% +$6.8K 0.02% 653
2016
Q2 		$8.11M Sell
94,251
-499
-0.5% -$43.1K 0.02% 631
2016
Q1 		$7.53M Sell
94,750
-1,371
-1% -$124K 0.02% 633
2015
Q4 		$12.1M Sell
96,121
-1,889
-2% -$228K 0.03% 492
2015
Q3 		$10.2M Buy
98,010
+2,208
+2% +$284K 0.03% 551
2015
Q2 		$11.8M Sell
95,802
-369,307
-79% -$46.5M 0.03% 513
2015
Q1 		$54.9M Sell
465,109
-3,386
-0.7% -$406K 0.12% 171
2014
Q4 		$55.7M Sell
468,495
-20,395
-4% -$2.3M 0.12% 165
2014
Q3 		$54.9M Sell
488,890
-17,889
-4% -$1.7M 0.12% 168
2014
Q2 		$48M Sell
506,779
-4,416
-0.9% -$310K 0.11% 201
2014
Q1 		$36.2M Buy
511,195
+11,519
+2% +$912K 0.08% 234
2013
Q4 		$37.1M Sell
499,676
-212,233
-30% -$14.8M 0.09% 226
2013
Q3 		$54M Sell
711,909
-26,549
-4% -$2.11M 0.13% 157
2013
Q2 		$59M Buy
+738,458
New +$54.4M 0.16% 130

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

VOYA Investment Management's VRTX Position: Q1 2026 in Review

VOYA Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 6.3% in Q1 2026, selling an estimated $16.5M and leaving 527,047 shares worth $235M. The position accounts for 0.24% of the portfolio, ranked #98.

VOYA Investment Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $695M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • VOYA Investment Management held 527,047 shares of Vertex Pharmaceuticals worth $235M as of Q1 2026.
  • VOYA Investment Management sold 35,305 Vertex Pharmaceuticals shares in Q1 2026, an estimated $16.5M.
  • Vertex Pharmaceuticals made up 0.24% of VOYA Investment Management's portfolio in Q1 2026, its #98 holding.
  • VOYA Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Vertex Pharmaceuticals position peaked at $695M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.